Cargando…
Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016417/ https://www.ncbi.nlm.nih.gov/pubmed/34958365 http://dx.doi.org/10.1210/clinem/dgab785 |
| _version_ | 1784688525576241152 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9016417 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90164172022-04-20 Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome J Clin Endocrinol Metab Online Only Articles Oxford University Press 2021-12-27 /pmc/articles/PMC9016417/ /pubmed/34958365 http://dx.doi.org/10.1210/clinem/dgab785 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Online Only Articles Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome |
| title | Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome |
| title_full | Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome |
| title_fullStr | Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome |
| title_full_unstemmed | Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome |
| title_short | Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome |
| title_sort | corrigendum to: denosumab reduces lesional fluoride skeletal burden on na[18f]f pet-ct in patients with fibrous dysplasia/mccune–albright syndrome |
| topic | Online Only Articles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016417/ https://www.ncbi.nlm.nih.gov/pubmed/34958365 http://dx.doi.org/10.1210/clinem/dgab785 |